Ann: wheezo Registered and Approved for Sale in the UK Market, page-26

Mondy, it seems you took it personally (very unnecessary), Are you one of the respiri management team.

But selling any number isn’t job of investor, we are here to understand growth and future of our investments. Leaving Australian sales as target isn’t good idea and if it had so many challenges then why Respiri kept onboarding so many pharmacy chains. That was all price sensitive and we all invested based on new team’s self acclaimed experience. Anyways I hope to see some positive sales in Australia than aggressive chats.